Skip to main content
SpringerLink
Log in

Idiopathic Short Stature

  • Chapter
  • First Online:
Pediatric Endocrinology

Part of the book series: Contemporary Endocrinology ((COE))

  • 2760 Accesses

Abstract

ISS describes a category of children with severe short stature and poor growth velocity in the absence of an identifiable cause. After a thorough evaluation has been conducted, a number of therapeutic options may be considered. The approval of ISS as an indication for GH treatment poses further challenges in optimizing management of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wit JM, Clayton PE, Rogol AD, Savage MO, Saenger PH, Cohen P. Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Horm IGF Res. 2008;18(2):89–110.

    Article  PubMed  CAS  Google Scholar 

  2. Topor LS, Feldman HA, Bauchner H, Cohen LE. Variation in methods of predicting adult height for children with idiopathic short stature. Pediatrics. 2010;126(5):938–45.

    Article  PubMed  Google Scholar 

  3. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr. 1952;40(4):423–41.

    Article  PubMed  CAS  Google Scholar 

  4. Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, Chernausek SD, Savage MO, Wit JM; for the 2007 ISS Consensus Workshop participants. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab. 2008;93(11):4210–7

    Google Scholar 

  5. Cohen P. Controversy in clinical endocrinology: problems with reclassification of IGF-1 production and action disorders. J Clin Endocrinol Metab. 2006;91:4235–6.

    Article  PubMed  CAS  Google Scholar 

  6. Savage MO, Cohen L, Cohen AJ, Cohen P, Saenger PH. Pathophysiology, assessment and management of the child with growth hormone resistance. Pediatr Endocrinol Rev. 2010;7:347–56.

    PubMed  CAS  Google Scholar 

  7. Hintz RL, Attie KM, Baptista J, Roche A; for the Genentech Collaborative Group. Effect of growth hormone treatment on adult height of children with idiopathic short stature. N Engl J Med. 1999;340(7):502–7.

    Google Scholar 

  8. Bakker B, Frane J, Anhalt H, Lippe B, Rosenfeld RG. Height velocity targets from the National Cooperative Growth Study for first year growth hormone responses in short children. J Clin Endocrinol Metab. 2008;93:352–7.

    Article  PubMed  CAS  Google Scholar 

  9. Keni J, Cohen P. Optimizing growth hormone dosing in children with idiopathic short stature. Horm Res. 2009;71 Suppl 1:70–4.

    Article  PubMed  CAS  Google Scholar 

  10. Park P, Cohen P. Insulin-like growth factor I (IGF-I) measurements in growth hormone (GH) therapy of idiopathic short stature (ISS). Growth Horm IGF Res. 2005;15(Suppl A):S13–20.

    Article  PubMed  CAS  Google Scholar 

  11. Wit JM, Reiter EO, Ross JL, Saenger PH, Savage MO, Rogol AD, Cohen P. Idiopathic short stature: management and growth hormone treatment. Growth Horm IGF Res. 2008;18(2):111–35.

    Article  PubMed  CAS  Google Scholar 

  12. Albertsson-Wikland K, Aronson AS, Gustafsson J, Hagenas L, Ivarsson SA, Jonsson B, Kristrom B, Marcus C, Nilsson KO, Ritzen EM, Tuvemo T, Westphal O, Aman J. Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency. J Clin Endocrinol Metab. 2008;93(11):4342–50.

    Article  PubMed  CAS  Google Scholar 

  13. Cohen P, Germak J, Rogol AD, Weng W, Kappelgaard AM, Rosenfeld RG; for the American Norditropin Study Group. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children. J Clin Endocrinol Metab. 2010;95(5):2089–98.

    Google Scholar 

  14. Cohen P. Growth hormone treatment: evidence, practice, and emerging issues. Manag Care. 2009;18(8 Suppl 6):2–3.

    PubMed  Google Scholar 

  15. Rosenbloom AL. Pediatric endo-cosmetology and the evolution of growth diagnosis and treatment. J Pediatr. 2011;158(2):187–93.

    Article  PubMed  Google Scholar 

  16. Shulman DI, Francis GL, Palmert MR, Eugster EA; for the Lawson Wilkins Pediatric Endocrine Society Drug and Therapeutics Committee. Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development. Pediatrics. 2008;121(4):e975–83

    Google Scholar 

  17. Wickman S, Sipilä I, Ankarberg-Lindgren C, Norjavaara E, Dunkel L. A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial. Lancet. 2001;357(9270):1743–8.

    Article  PubMed  CAS  Google Scholar 

  18. Hero M, Norjavaara E, Dunkel L. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial. J Clin Endocrinol Metab. 2005;90(12):6396–402.

    Article  PubMed  CAS  Google Scholar 

  19. Hero M, Wickman S, Dunkel L. Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty. Clin Endocrinol. 2006;64(5):510–3.

    Article  CAS  Google Scholar 

  20. Mauras N, Gonzalez de Pijem L, Hsiang HY, Desrosiers P, Rapaport R, Schwartz ID, Klein KO, Singh RJ, Miyamoto A, Bishop K. Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years. J Clin Endocrinol Metab. 2008;93(3):823–31.

    Article  PubMed  CAS  Google Scholar 

  21. Mauras N. Strategies for maximizing growth in puberty in children with short stature. Endocrinol Metab Clin North Am. 2009;38(3):613–24.

    Article  PubMed  CAS  Google Scholar 

  22. Hero M, Dunkel L. Aromatase inhibitors in bone and growth plate. 47th Annual Meeting European Society of Pediatric Endocrinology Annual Scientific Meeting. Horm Res. 2008;70:13.

    Article  Google Scholar 

  23. Chernausek SD, Backeljauw PF, Frane J, Kuntze J, Underwood LE. Long-term treatment with recombinant IGF-I in children with severe IGF-I deficiency due to growth hormone insensitivity. J Clin Endocrinol Metab. 2007;92:902–10.

    Article  PubMed  CAS  Google Scholar 

  24. Midyett LK, Rogol AD, Van Meter QL, Frane J, Bright GM; for the MS301 Study Group. Recombinant insulin-like growth factor (IGF)-1 treatment in short children with low IGF-1 levels: first-year results from a randomized clinical trial. J Clin Endocrinol Metab. 2010;95(2):611–19

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatrics, UCLA Medical Center, Mattel Children’s Hospital, 10833 Le Conte Ave, MDCC 22-315, Los Angeles, CA, 90095, USA

    Yung-Ping Chin M.D. & Pinchas Cohen M.D.

Authors
  1. Yung-Ping Chin M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pinchas Cohen M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yung-Ping Chin M.D. .

Editor information

Editors and Affiliations

  1. School of Medicine, Department of Pediatrics, The Johns Hopkins University, 600 North Wolfe St., Baltimore, 21287, Maryland, USA

    Sally Radovick

  2. , Department of Pediatrics, Children's Hospital of Buffalo, 219 Bryant St., Buffalo, 14222, New York, USA

    Margaret H. MacGillivray

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Chin, YP., Cohen, P. (2013). Idiopathic Short Stature. In: Radovick, S., MacGillivray, M. (eds) Pediatric Endocrinology. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-395-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-395-4_4

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-394-7

  • Online ISBN: 978-1-60761-395-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation